NHS National Pharmaceuticals Transition 2021_3
Details
- Buyer
- NHS England
- Supplier(s)
36 suppliers
- Accord UK Ltd
- Aguettant Ltd
- Alturix
- Amarox Ltd
- Ambe Medical Group Ltd
- Aspen Pharmacare UK Limited
- Aspire Pharma Ltd
- Brown and Burk
- Cipla (EU) Ltd
- Colonis Pharma Limited
- Consilient Health Ltd
- CST Pharma Limited
- Day Lewis Medical Ltd
- Dr Reddy's Laboratories (UK) Ltd
- DRUGSRUS LIMITED
- Glenmark Pharmaceuticals Europe Ltd
- Kensington Pharma Ltd
- Kent Pharma Ltd
- Laboratorio Reig Jofre SA
- Lucane Pharma
- Macure Pharma ApS
- medac Pharma LLP
- Mercury Pharmaceuticals Ltd
- Morningside Pharmaceuticals Ltd
- Mylan
- Napp Pharmaceuticals Ltd
- Panpharma UK Ltd
- Pfizer Liimted
- Ranbaxy UK
- Roche Products Ltd
- Seacross Pharmaceuticals Ltd
- Teva UK Ltd
- Thornton and Ross
- Torbay Pharmaceuticals
- Wockhardt UK Limited
- Zentiva Pharma UK Ltd
- Value
- £25,983,607
- Duration
- 3 years
- Topic
- Pharmaceutical products
- Published
- 4 November 2021
- Source
- uk:contracts_finder
Tender description
NHS National PharmaceuticalsTransition 2021_3 Offer reference number:CM/PHG/21/5633
Timeline
- Completed: Award date1 October 2021
- Completed: Award published4 November 2021Current notice
- Completed: Contract expiry date31 May 2024
About the buyer
NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Every tender is advertised on Atamis, the NHS's single eCommercial system, and larger contracts appear on Find a Tender. Much of this procurement flows through framework agreements and the Crown Commercial Service. Clinical services are commissioned directly or through the Provider Selection Regime. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.
UK health spending has nearly quadrupled to £241.8bn in 2024/25, £20bn up on the year before. £140.6bn of that went to procurement, the biggest sector of UK public spending and the fastest-growing.
Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
14 similar open tenders
See more open tenders related to NHS National Pharmaceuticals Transition 2021_3.
- Open tender
Generic Drugs - Injections/Infusions
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
Related buyers
Buyers similar to NHS England.
- 509£245.0m
- 429£15.3bn
- 426£117.3m
- 380£641.6m
- 320£18.9bn
- 298£3.1bn
- 295£1.7bn
- 269£1.2bn
- 153£987.8m
- 147£115.2m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
